Cetero records $3.1 million net loss in April; Abbott and Syngene open new R&D center in India;

 @NesaNFierce: Catalent's renovated fill-finish plant in NC is more in-tune with the company's renewed business focus. Article | Follow @NesaNFierce

> Cetero Research recorded a net loss of $3.1 million in April due in large part of its company restructuring and redoing work for the FDA. Article

> Quintiles has signed licensing agreements that enable the CRO to gain access to electronic medical records data representing 40 million patients. News

> Abbott Laboratories ($ABT) and Syngene opened their state-of-the-art nutrition R&D center in Bangalore, India. It is the first facility of its kind in the country, the companies say. Story

> PacificGMP and Vasgene Therapeutics announced that they have successfully completed the large-scale manufacturing of Vasgene's recombinant fusion protein for use in its Phase I clinical trial. Release

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.